Loading company…
SoniVie develops a catheter-based ultrasound device for treating pulmonary artery hypertension and other conditions.
SoniVie develops TIVUS, a catheter-based therapeutic intravascular ultrasound system for pulmonary artery hypertension, with patient groups also including people with COPD and resistant hypertension. Founded in 2014, the medical device company is based in Rehovot, Israel. In January 2023, Andera Partners, Omega Funds, Supernova Invest, and Techwald Holding led its USD 60 million Series C round.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in